Acquisition of the building of Clinique Nescens Paris Spontini

AEVIS VICTORIA SA / Key word(s): Acquisition

30-Oct-2019 / 07:00 CET/CEST

Release of an ad hoc announcement pursuant to Art. 53 KR

The issuer is solely responsible for the content of this announcement.

Press release

Fribourg, 30 October 2019

AEVIS VICTORIA SA: Acquisition of the building of Clinique Nescens Paris Spontini

AEVIS VICTORIA, through its French subsidiary SAS Clinique Spontini, announces that it has acquired the real estate company SCI François 1er and thus became the owner of the Clinique Nescens Paris Spontini building, located at 68bis rue Spontini, in the 16th Arrondissement of Paris. The market value of the building, with a gross surface area of 1’250m2, amounts to nearly EUR 15 million.

Clinique Nescens Paris Spontini is a specialised health establishment dedicated to aesthetic surgery, medicine and care. Dedicated exclusively to well-being and beauty, Clinique Nescens Paris Spontini offers a medical and hotel infrastructure that is highly appreciated by national and international clients and by the doctors and health professionals who work there.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey,, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren,, +41 (0) 79 635 04 10

AEVIS VICTORIA SA – Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA, the second largest group of private hospitals in Switzerland, Victoria-Jungfrau Collection AG, a luxury hotel group managing four luxury hotels in Switzerland, Infracore SA (19%), a real estate company dedicated to healthcare-related infrastructure, a hospitality real estate division, Medgate (40%), the leading telemedicine provider in Switzerland, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW).

End of ad hoc announcement

show this

This website uses cookies.
Please see our Privacy Guidelines for further details.